Manufacturer: Eli Lilly and Company Limited Active Substance(s): TIRZEPATIDE Strength: 12.5mg/per 0.6 ml injection Pack Size: 1 box with 4 pre-filled KwikPens MOUNJARO 12.5mg KwikPen is a once-weekly tirzepatide injection in a pre-filled pen delivering four 12.5mg/0.6ml doses for adults with type 2 diabetes and, in some regions, chronic weight management
The key difference is that semaglutide users at the 2.4 mg dose report higher rates and longer duration of constipation compared to tirzepatide users, even at the highest 15 mg dose
However, this is an average from studies, and your timeline will depend on a combination of factors, including your starting weight, dosage, and commitment to lifestyle changes
Other GLP-1 weight loss medications Tirzepatide isn't the only effective option for tirzepatide weight loss injections
Choosing easily digestible foods, particularly during the initial weeks of treatment, supports better tolerance